A paradigm change in the treatment of blinding ocular diseases

Project Information

TRS

Grant agreement ID: 879598

DOI 10.3030/879598

Project closed

EC signature date 3 September 2019

Start date 1 July 2019

End date 30 June 2021

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 3 461 500,00

EU contribution € 2 423 050,00

Coordinated by

TARSIER PHARMA LTD
Israel

Deliverables

Websites, patent fillings, videos etc. (1)

D4.2 Project website updated to include clinical trials info

Publications

Peer reviewed articles (1)

Tarsier Anterior Chamber Cell Grading: Improving the SUN Grading Scheme with a Visual Analog Scale

Author(s): Marc D. de Smet, Daphne Haim-Langford, Ron Neumann, Michal Kramer, Emmett Cunningham, Lisa Deutsch, Zohar Milman
Published in: Ocular Immunology and Inflammation, 2021, Page(s) 1-6, ISSN 0927-3948
Publisher: Swets & Zeitlinger
DOI: 10.1080/09273948.2021.1934036

Intellectual Property Rights

Other (1)

Non Proprietary name for TRS01INN/RB/mc P5-180/19 (12018)

Application/Publication number: WHO 12018
Date: 2020-12-23
Applicant(s): TARSIER PHARMA LTD

Trademark (1)

Trademark Application No. 90354312 - TARSIER

Application/Publication number: EU 018484230
Date: 2020-12-02
Applicant(s): TARSIER PHARMA LTD